Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195

NCT02881853 is registered in ClinicalTrials.gov with Xencor, Inc. as lead sponsor.

NCT NCT02881853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02881853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195
Lead sponsor
Xencor, Inc.
Phase
Phase 1
Overall status
Completed
Start date
August 17, 2016
Completion date
February 24, 2017
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic disease, healthy volunteers